Advertisement

Topics

Hopping on restructuring bandwagon, Shire looks to spin off neuroscience unit

05:11 EDT 3 Aug 2017 | BioPharmaDive

Amid talk of increased sales and improved Baxalta synergies, Shire's CEO dropped the divestiture bombshell.

Original Article: Hopping on restructuring bandwagon, Shire looks to spin off neuroscience unit

NEXT ARTICLE

More From BioPortfolio on "Hopping on restructuring bandwagon, Shire looks to spin off neuroscience unit"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...